A Kansas City CBD company received a warning letter from the FDA

Kansas City, Mo – A Kansas City-based CBD producer received warning letter from the US Food and Drug Administration for several violations, including making products that could be considered attractive to children.

The FDA sent a letter on November 16 to the CEO of CBD American Shaman Stephen Vincent Sanders II, KSNT report. The extensive document shows the company’s CBD products and lists several violations that need to be corrected.

Many products are listed as counterfeit because they contain unsafe food additives. This is defined by uslegal.com as: “Adulterated means to make something impure by adding foreign or inferior material. Adulteration can be done to edible or other commercial goods.

This product includes:

  • CBD Suckers
  • CBD hard candy
  • Cookies [with] 10mg of CBD per serving
  • CBD Sparkling Tea
  • CBD Sparkling Water
  • CBD coffee
  • CBD Honey Stick
  • CBD Honey
  • Doggy Chews (all flavors)
  • Soft & Soft Doggy Chews
  • Horsey Chews
  • Doggy Nugs
  • Kitty Nugs

The FDA states that it is prohibited conduct to introduce this product into interstate commerce.

However, the FDA reported in its letter that it is “particularly concerned” about products sold by American Physicians that may appear attractive to children. These products include CBD Suckers, CBD Hard Candies, various Cookies [with] 10mg CBD per serving and various CBD Gummies products.

The warning letter also states that such products have not been evaluated for safety, effectiveness and quality and may be unpredictable when used by vulnerable populations such as children.

Children may be at greater risk for adverse reactions associated with certain drug products due to differences in the ability of children to absorb, metabolize, distribute or excrete such drug products or their metabolites, according to the FDA.

Other violations listed by the FDA include confusing marketing practices, selling an unapproved new drug “CBD + ZINC OXIDE Sunscreen” and marketing products containing CBD for pets that are not approved new animal drugs.

The letter ended with the FDA requiring CBD American Healer to respond within 15 business days with specific steps taken to correct the violation. An explanation of each step taken to prevent the recurrence of the violation and a copy of the related documentation is required.

Leave a Reply

Your email address will not be published. Required fields are marked *